EW vs MRSN · P/E 47, rev $3.39B vs rev $40.5M
Edwards Lifesciences Corp (EW) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the EW and MRSN stock pages for the full models.
Not investment advice.